Anti-oxidants in astrocytes as target of neuroprotection for parkinson’s disease

Medicine & Life Sciences

• Neuroprotection 100%
• Astrocytes 87%
• Parkinson Disease 79%
• Antioxidants 70%
• Cystine 70%
• Metallothionein 67%
• Phytochemicals 29%
• zinc-binding protein 19%
• Serotonin 5-HT1 Receptor Agonists 18%
• Amino Acid Transport System X-AG 18%
• Receptor, Serotonin, 5-HT1A 16%
• Neuroprotective Agents 13%
• Anticonvulsants 12%
• Cysteine 12%
• Nervous System Diseases 12%
• Glutathione 12%
• Transcription Factors 10%
• Central Nervous System 10%
• Neurons 8%